US Stock MarketDetailed Quotes

CANF Can-Fite BioPharma

Watchlist

2.3700
+0.1600+7.24%

Close Aug 23 16:00 ET

11.83MMarket Cap-790P/E (TTM)

Can-Fite BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Can-Fite BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q2	-- / 150.000K	--
--	2024/Q1	-- / 150.000K	--
--	2023/Q4	155.000K / 200.000K	--
--	2023/Q3	196.000K / 200.000K	--
--	2023/Q2	196.000K / 200.000K	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q2-- / 150.000K--

--2024/Q1-- / 150.000K--

--2023/Q4155.000K / 200.000K--

--2023/Q3196.000K / 200.000K--

--2023/Q2196.000K / 200.000K--

Unlock Free Earnings Estimates

Open Account

Can-Fite BioPharma Earnings Reports

Can-Fite BioPharma | 6-K/A: Report of foreign private issuer (related to financial reporting)

Jun 7 16:20 ET

Can-Fite BioPharma | 6-K: Report of foreign private issuer (related to financial reporting)

May 22 16:20 ET

Can-Fite BioPharma | 20-F: FY2023 Annual Report

Mar 28 09:34 ET

Can-Fite BioPharma | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 28 07:09 ET

Analyst Rating

Updated: Aug 9, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall